Influence of internal mammary node irradiation on long-term outcome and contralateral breast cancer incidence in node-negative breast cancer patients - PubMed
Comparative Study
. 2013 Aug;108(2):259-65.
doi: 10.1016/j.radonc.2013.06.028. Epub 2013 Jul 25.
Affiliations
- PMID: 23891092
- DOI: 10.1016/j.radonc.2013.06.028
Comparative Study
Influence of internal mammary node irradiation on long-term outcome and contralateral breast cancer incidence in node-negative breast cancer patients
Adel Courdi et al. Radiother Oncol. 2013 Aug.
Abstract
Background and purpose: There is no general consensus concerning irradiation (RT) of internal mammary nodes (IMN) in axillary node-negative breast cancer. Based on a large series of patients treated in a single institute and followed up for a long period of time, we looked at the influence of IMN RT on late outcome of these patients as well as the development of contralateral breast cancer (CBC).
Patients and methods: The study was based on 1630 node-negative breast cancer patients treated in our institution between 1975 and 2008 with primary conservative surgery and axillary dissection or sentinel node examination. All patients received post-operative breast RT. IMN RT was more frequent in inner or central tumours. Kaplan-Meier (K-M) overall survival (OS), cancer-specific survival (CSS), and disease-free survival (DFS) according to IMN RT were calculated for all patients and for patients with inner/central tumours. The K-M rate of contralateral breast cancer (CBC) was also analysed and correlated with IMN RT.
Results: Prognostic variables such as tumour size, histological grade, and hormone receptors were not significantly different in the groups having received IMN RT or not. Considering all patients, OS was strictly comparable in the 2 groups: 10-year values were 85% (IMN RT) and 86% (no IMN RT), respective values at 20 years were 66.6% and 61.0% (p=0.95). However, in patients presenting with inner/central tumours, OS was significantly improved in the IMN RT group with respective values of 92.5% and 87.2% at 10 years, and 80.2% and 63.3% at 20 years: Hazard ratio (HR)=0.56 (0.37-0.85); p=0.0052. Again, CSS was improved in patients with inner/central tumours having received IMN RT, with 20-year rates of 89.5% versus 79.1% in patients not receiving IMN RT (p=0.047). No difference in DFS was noticed. The actuarial rate of CBC development was comparable between patients having received IMN RT and other patients. However, considering only patients alive 10 years after primary breast surgery, the K-M rate of CBC at 20 years was 5.3% in patients without IMN RT and 7.2% in patients with such RT; HR=2.47 (1.23-4.95); p=0.008.
Conclusions: IMN RT in node-negative tumours was associated with increase in OS and CSS in patients with inner or centrally located lesions. An increase in CBC development was also noticed in long-survivors of IMN RT patients; however, these findings have to be interpreted with caution because of the difference in follow-up between the 2 groups. Further studies are warranted to investigate the potential role of IMN irradiation in the development of CBC.
Keywords: Contralateral breast cancer; Inner tumours; Internal mammary nodes irradiation; Outcome; Survival.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.
Comment in
-
[The pendulum swings back - lymphatic irradiation of breast cancer is in favor again].
Klages HT. Klages HT. Strahlenther Onkol. 2014 May;190(5):494-6. doi: 10.1007/s00066-014-0621-5. Strahlenther Onkol. 2014. PMID: 24847510 German. No abstract available.
Similar articles
-
Sávolt A, Musonda P, Mátrai Z, Polgár C, Rényi-Vámos F, Rubovszky G, Kovács E, Sinkovics I, Udvarhelyi N, Török K, Kásler M, Péley G. Sávolt A, et al. Orv Hetil. 2013 Dec 8;154(49):1934-42. doi: 10.1556/OH.2013.29765. Orv Hetil. 2013. PMID: 24292111 Clinical Trial. Hungarian.
-
Fowble B, Hanlon A, Freedman G, Nicolaou N, Hoffman J, Sigurdson E, Boraas M, Torosian M, Goldstein L. Fowble B, et al. Int J Radiat Oncol Biol Phys. 2000 Jul 1;47(4):883-94. doi: 10.1016/s0360-3016(00)00526-5. Int J Radiat Oncol Biol Phys. 2000. PMID: 10863056
-
Hannoun-Levi JM, Resch A, Gal J, Kauer-Dorner D, Strnad V, Niehoff P, Loessl K, Kovács G, Van Limbergen E, Polgár C; GEC-ESTRO Breast Cancer Working Group. Hannoun-Levi JM, et al. Radiother Oncol. 2013 Aug;108(2):226-31. doi: 10.1016/j.radonc.2013.03.026. Epub 2013 May 3. Radiother Oncol. 2013. PMID: 23647758
-
Is regional nodes radiotherapy an alternative to surgery?
Offersen BV, Nielsen HM, Overgaard M, Overgaard J. Offersen BV, et al. Breast. 2013 Aug;22 Suppl 2:S118-28. doi: 10.1016/j.breast.2013.07.023. Breast. 2013. PMID: 24074772 Review.
-
Manca G, Volterrani D, Mazzarri S, Duce V, Svirydenka A, Giuliano A, Mariani G. Manca G, et al. Q J Nucl Med Mol Imaging. 2014 Jun;58(2):114-26. Q J Nucl Med Mol Imaging. 2014. PMID: 24835288 Review.
Cited by
-
The role of radiotherapy in the management of nodal disease in breast cancer.
Lenihan J, Rangaswamy G, Faul C. Lenihan J, et al. Rep Pract Oncol Radiother. 2022 May 19;27(2):331-343. doi: 10.5603/RPOR.a2022.0037. eCollection 2022. Rep Pract Oncol Radiother. 2022. PMID: 36299373 Free PMC article. Review.
-
The lymph node microenvironment and its role in the progression of metastatic cancer.
Pereira ER, Jones D, Jung K, Padera TP. Pereira ER, et al. Semin Cell Dev Biol. 2015 Feb;38:98-105. doi: 10.1016/j.semcdb.2015.01.008. Epub 2015 Jan 22. Semin Cell Dev Biol. 2015. PMID: 25620792 Free PMC article. Review.
-
Nomogram to Predict Internal Mammary Lymph Nodes Metastasis in Patients With Breast Cancer.
Xie X, Xiong Z, Li X, Huang X, Ye F, Tang H, Xie X. Xie X, et al. Front Oncol. 2019 Nov 8;9:1193. doi: 10.3389/fonc.2019.01193. eCollection 2019. Front Oncol. 2019. PMID: 31781496 Free PMC article.
-
Novikov SN, Kanaev SV, Semiglazov VF, Jukova LA, Krzhivitckiy PI. Novikov SN, et al. Rep Pract Oncol Radiother. 2014 Jul 19;20(1):27-31. doi: 10.1016/j.rpor.2014.06.001. eCollection 2015 Jan. Rep Pract Oncol Radiother. 2014. PMID: 25535581 Free PMC article.
-
Qi WX, Cao L, Xu C, Cai G, Chen J. Qi WX, et al. Front Oncol. 2023 Jan 31;13:1081201. doi: 10.3389/fonc.2023.1081201. eCollection 2023. Front Oncol. 2023. PMID: 36798812 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical